Clinical Research Directory
Browse clinical research sites, groups, and studies.
Collection of Sequential Samples From Patients With Malignant Myeloid Hemopathy for the Study of Treatment Resistance
Sponsor: Institut Paoli-Calmettes
Summary
The main objective is to study the genomic, transcriptomic, proteomic epigenomic, metabolomic and immune mechanisms of blasts and microenvironment cells associated with IT resistance through the constitution of a collection associating blood or marrow samples from patients with LA, MDS and MPS marrow samples from patients with LA, MDS and MPS at diagnosis, during treatment and at relapse and relapse and clinical annotations.
Official title: Collection of Sequential Samples From Patients With Malignant Myeloid Hemopathy for the Study of Treatment Resistance: HEMATOBIO.02-IPC 2021-061
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
400
Start Date
2023-01
Completion Date
2030-01
Last Updated
2022-11-01
Healthy Volunteers
No
Conditions
Interventions
experimental:Acute leukemia/myelodysplastic or myeloproliferative disease
blood sampling, bone marrow aspirate and buccal swab